Water → N-Butyl-N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(3-(2-(4-(2-isopropylthiazole-4-carbonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-9-yl)ethyl)phenethoxy)propanamide monosulphate salt

HRID 1255343Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1255343
[CH2:1]([N:5]([CH2:42][CH2:43][NH:44][CH2:45][CH2:46][C:47]1[C:52]2[O:53][CH2:54][C:55](=[O:57])[NH:56][C:51]=2[C:50]([OH:58])=[CH:49][CH:48]=1)[C:6](=[O:41])[CH2:7][CH2:8][O:9][CH2:10][CH2:11][C:12]1[CH:17]=[CH:16][CH:15]=[C:14]([CH2:18][CH2:19][N:20]2[CH2:40][CH2:39][C:23]3([O:28][CH2:27][CH2:26][N:25]([C:29]([C:31]4[N:32]=[C:33]([CH:36]([CH3:38])[CH3:37])[S:34][CH:35]=4)=[O:30])[CH2:24]3)[CH2:22][CH2:21]2)[CH:13]=1)[CH2:2][CH2:3][CH3:4].[S:59](=[O:63])(=[O:62])([OH:61])[OH:60].O>CCO.CC#N>[S:59]([OH:63])([OH:62])(=[O:61])=[O:60].[CH2:1]([N:5]([CH2:42][CH2:43][NH:44][CH2:45][CH2:46][C:47]1[C:52]2[O:53][CH2:54][C:55](=[O:57])[NH:56][C:51]=2[C:50]([OH:58])=[CH:49][CH:48]=1)[C:6](=[O:41])[CH2:7][CH2:8][O:9][CH2:10][CH2:11][C:12]1[CH:17]=[CH:16][CH:15]=[C:14]([CH2:18][CH2:19][N:20]2[CH2:40][CH2:39][C:23]3([O:28][CH2:27][CH2:26][N:25]([C:29]([C:31]4[N:32]=[C:33]([CH:36]([CH3:37])[CH3:38])[S:34][CH:35]=4)=[O:30])[CH2:24]3)[CH2:22][CH2:21]2)[CH:13]=1)[CH2:2][CH2:3][CH3:4]

Komponenten

6

Edukt 3

HCID 962WaterHCID 1118Sulfuric AcidHCID 51036603N-Butyl-N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(3-(2-(4-(2-isopropylthiazole-4-carbonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-9-yl)ethyl)phenethoxy)propanamide

Produkt 1

HCID 86651693N-Butyl-N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(3-(2-(4-(2-isopropylthiazole-4-carbonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-9-yl)ethyl)phenethoxy)propanamide monosulphate salt

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 702EthanolLösungsmittelHCID 6342AcetonitrileLösungsmittel

Versuchsvorschrift

N-butyl-N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(3-(2-(4-(2-isopropylthiazole-4-carbonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-9-yl)ethyl)phenethoxy)propanamide (limiting reagent) was dissolved in EtOH (15 vols) and 4.9M sulphuric acid (1 molar equivalent) was added and the solution was stirred at room temp for 48 hours. The precipitate was collected, washed with EtOH (1 voll) and vacuum dried (oven at 40° C., oil pump) to leave a white solid (70% recovery). 5% water in MeCN (20 volumes) was added and the mixture stirred for 6 days. Crystalline solid (form G) was then collect by filtration (95% recovery).

Aufarbeitung

  1. customThe precipitate was collected
  2. washwashed with EtOH (1 voll) and vacuum
  3. customdried (oven at 40° C., oil pump)
  4. customto leave a white solid (70% recovery)
  5. stirringthe mixture stirred for 6 days
  6. filtrationCrystalline solid (form G) was then collect by filtration (95% recovery)

Quellen und Nachweise

ORD-Eintrag
ord-1d968194bce54db4b4c0622f8038a197
Quelldatensatz
uspto-grants-2013_06
Patentnummer
US08455483B2

Notizen zur Reaktion

Wird geladen…